Neurological effects of Mycoplasma pneumoniae infection.
Penington
G R
GR
D000293:Adolescent; D000900:Anti-Bacterial Agents; D018450:Disease Progression; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D004660:Encephalitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005500:Follow-Up Studies; D006212:Hallucinations / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008297:Male; D009177:Mycoplasma pneumoniae / Q000302:isolation & purification*; D011019:Pneumonia, Mycoplasma / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D018570:Risk Assessment; D012640:Seizures / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents